David Barros-Aguirre
15PUBLICATIONS
62CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (15)
Sort by Publication Date:
|Apr 07, 2026
Alpibectir-Ethionamide combination (AlpE) for the treatment of tuberculosis.Zainab Edoo, Camille Grosse, Thomas Maitre
|Sep 30, 2024
Contribution of direct InhA inhibitors to novel drug regimens in a mouse model of tuberculosis.Lourdes Encinas, Si-Yang Li, Joaquin Rullas-Trincado
|Feb 20, 2024
Bactericidal and sterilizing activity of novel regimens combining bedaquiline or TBAJ-587 with GSK2556286 and TBA-7371 in a mouse model of tuberculosis.Si-Yang Li, Sandeep Tyagi, Heena Soni
|Feb 16, 2024
A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial.Andreas H Diacon, Clifton E Barry, Alex Carlton
|Jan 23, 2023
Activity of Oral Tebipenem-Avibactam in a Mouse Model of Mycobacterium abscessus Lung Infection.Dereje A Negatu, Rubén González Del Río, Mónica Cacho-Izquierdo
|May 24, 2022
GSK2556286 Is a Novel Antitubercular Drug Candidate Effective In Vivo with the Potential To Shorten Tuberculosis Treatment.Eric L Nuermberger, Maria Santos Martínez-Martínez, Olalla Sanz
Pageof 3
Frequent Collaborators
4 joint publications
Véronique Dartois
3 joint publications
Eric L Nuermberger
3 joint publications
Mónica Cacho-Izquierdo
3 joint publications
Thomas Dick
3 joint publications
Martin Gengenbacher
2 joint publications
Esther Pérez-Herrán
2 joint publications
Koen Augustyns
2 joint publications
Pieter Van der Veken
2 joint publications
René Wintjens
2 joint publications
Vanessa Mathys
